Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic target for managing metabolic syndromes. These naturally occurring molecules are secreted by the gut in response to food intake, https://thesocialdelight.com/story6028101/unveiling-the-therapeutic-potential-of-glp-1-peptides